Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)Masahiro Fukuoka, Tony Mok, Tsu-Yi Chao et al.|Journal of Clinical Oncology|2011Cited by 1.6k
Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 SignalingChien‐Tai Hong, Oluwaseun Adebayo Bamodu, Kai‐Yun Chen et al.|Cells|2020Cited by 131
Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448Oluwaseun Adebayo Bamodu, Tsu-Yi Chao|BMC Cancer|2016Cited by 119